ARA 290
ARA290, a peptide designed to activate the innate repair receptor that arrests injury and initiates cytoprotection, anti-inflammation, and healing, reduces allodynia in preclinical neuropathy models.

ARA 290 is a synthetic 11-amino acid peptide IRR agonist. It is currently being assessed in the clinical developmental program for its ability to relieve symptoms related with sarcoidosis SFN and for the potential for disease modification and long-term functional enhancement in this condition.